Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 75,357Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3Strides Pharma Science

02 32care4

03 1Abacus Medicine

04 1Abdi Ibrahim

05 4Accord healthcare

06 2Alkem Laboratories

07 7Arcutis Biotherapeutics

08 16AstraZeneca

09 2Aurobindo Pharma Limited

10 2Aurovitas Spain, Sau

11 2Ferrer Internacional

12 2Hetero Drugs

13 1KMS Health Center

14 1MS Pharma

15 2MSN Laboratories

16 1Medartuum

17 2Micro Labs Limited

18 1ORIFARM GROUP AS

19 1Orchid Pharma

20 1PHARMOBEDIENT

21 1Precise Group

22 1Prinston

23 2Senores Pharmaceuticals

24 1Takeda Pharmaceutical

25 4Torrent Pharmaceuticals Limited

26 2Zydus Pharmaceuticals

27 1Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info : RX

Registration Country : USA

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2020-03-30

Application Number : 208247

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info : RX

Registration Country : USA

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-06-20

Application Number : 208247

Regulatory Info : RX

Registration Country : USA

Strides Pharma Science

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSynergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.

Regulatory Info :

Registration Country : India

Roflumilast

Brand Name : Roflumilast

Dosage Form : Tablet

Dosage Strength : 500MCG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Strides Pharma Science

04

Alkem Laboratories

IMCAS World Congress
Not Confirmed
arrow

Alkem Laboratories

arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 212490

Regulatory Info : RX

Registration Country : USA

blank

05

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : DALIRESP

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2011-02-28

Application Number : 22522

Regulatory Info : RX

Registration Country : USA

blank

06

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : DALIRESP

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2018-01-23

Application Number : 22522

Regulatory Info : RX

Registration Country : USA

blank

07

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-11-23

Application Number : 208213

Regulatory Info : RX

Registration Country : USA

blank

08

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208213

Regulatory Info : RX

Registration Country : USA

blank

09

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2019-03-22

Application Number : 208180

Regulatory Info : RX

Registration Country : USA

blank

10

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208180

Regulatory Info : RX

Registration Country : USA

blank

11

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2022-09-07

Application Number : 208256

Regulatory Info : RX

Registration Country : USA

blank

12

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-09-07

Application Number : 208256

Regulatory Info : RX

Registration Country : USA

blank

13

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-05-10

Application Number : 208299

Regulatory Info : RX

Registration Country : USA

blank

14

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-10-03

Application Number : 208236

Regulatory Info : DISCN

Registration Country : USA

blank

15

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-10-19

Application Number : 208236

Regulatory Info : DISCN

Registration Country : USA

blank

16

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-08-06

Application Number : 208272

Regulatory Info : DISCN

Registration Country : USA

blank

17

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2024-10-18

Application Number : 208272

Regulatory Info : DISCN

Registration Country : USA

blank

18

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2022-02-10

Application Number : 208303

Regulatory Info : RX

Registration Country : USA

blank

19

IMCAS World Congress
Not Confirmed
arrow
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 250MCG

Packaging :

Approval Date : 2023-04-18

Application Number : 208303

Regulatory Info : RX

Registration Country : USA

blank

20

PHARMOBEDIENT

Country
IMCAS World Congress
Not Confirmed
arrow

PHARMOBEDIENT

Country
arrow
IMCAS World Congress
Not Confirmed

ROFLUMILAST

Brand Name : ROFLUMILAST

Dosage Form : TABLET;ORAL

Dosage Strength : 500MCG

Packaging :

Approval Date : 2018-07-13

Application Number : 208257

Regulatory Info : RX

Registration Country : USA

blank